CRC Research Update — August 24, 2026
Today's colorectal cancer research highlights
adjuvant
A collection of 50 issues
Study Identifies Risk Factors for Serious Intestinal Side Effect With CAPOX Chemotherapy
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Study Identifies Risk Factors for Serious Intestinal Side Effect With CAPOX Chemotherapy
Researchers examined the incidence and risk factors of non-neutropenic enterocolitis—a serious intestinal inflammation—in colorectal cancer patients receiving adjuvant capecitabine and oxaliplatin (CAPOX) chemotherapy. (Clinical Colorectal Cancer)
This
CRC Research Update — August 18, 2026
Today's colorectal cancer research highlights
ctDNA-Guided Surveillance Doubles Curative Treatment Rate for Recurrent CRC
Skip to content
The CRC Digest
◆ TRIAL DATA
ctDNA-Guided Surveillance Doubles Curative Treatment Rate for Recurrent CRC
In the phase III FIND trial, patients monitored with circulating tumor DNA testing after surgery were twice as likely to receive curative-intent treatment when cancer recurred compared to standard surveillance (48.1% vs
CRC Research Update — August 15, 2026
Today's colorectal cancer research highlights
Adjuvant chemotherapy benefits occur early, not in late recurrences
Skip to content
The CRC Digest
◆ TRIAL DATA
Adjuvant chemotherapy benefits occur early, not in late recurrences
A systematic review of phase III randomized controlled trials for gastrointestinal malignancies including colorectal cancer found that recurrence-free survival improvements were driven by early divergences during active chemotherapy, while late recurrences were not
CRC Research Update — August 13, 2026
Today's colorectal cancer research highlights
Phase III trial launches to prevent oxaliplatin-induced neuropathy in adjuvant treatment
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Phase III trial launches to prevent oxaliplatin-induced neuropathy in adjuvant treatment
The PROSPER trial will test lecithinized superoxide dismutase (PC-SOD) against placebo to prevent chemotherapy-induced peripheral neuropathy in stage II/III colorectal cancer patients receiving adjuvant mFOLFOX6, following promising phase II
CRC Research Update — August 07, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 01, 2026
Today's colorectal cancer research highlights